
Pulled from Benzinga Pro data, DexCom (NASDAQ:DXCM) posted Q1 earnings of $97.30 million, an increase from Q4 of 601.55%. Sales dropped to $628.80 million, a 9.94% decrease between quarters. DexCom collected $698.20 million in revenue during Q4, but reported earnings showed a $19.40 million loss.